Amphista Therapeutics Appoints New Chairman, Joshua T Brumm prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
01.29.21 How To Establish An Effective CRO Partnership
Continuing our Cell & Gene Series,
Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode.
Video
Josh Brumm, CEO of Dyne Therapeutics, discusses some of the “pros” to pitching virtually. Keith Vendola, M.D., CSO, and head of strategy at Rezolute, adds to the conversation by discussing the difficulty of making a human connection via Zoom. This is a segment of a larger executive virtual roundtable (EVR) that also included Markus Warmuth, M.D., CEO, of Monte Rosa Therapeutics, on the topic of “Pitching and Fundraising in the New Norm.”